Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents
Synlett · 23.10.2025 · 36 (17) · 2939-2947
DOI: 10.1055/a-2541-1072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 23.10.2025. Verfasst von Halil Şenol und 7 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
In this study, 10 new rhodanine and thiazolidine-2,4-dione derivatives based on Mannich-modified vanillin were synthesized, characterized, and evaluated for their anticancer potential against A549 lung cancer and BEAS-2B normal cells. Among them, compound 5c exhibited the most potent anticancer activity, with an IC50 of 2.43 μM and a selectivity index of 10.91, showing higher selectivity than the reference drug sorafenib. Molecular docking studies suggested 5c as a strong potential epidermal growth factor receptor (EGFR) inhibitor, supported by a docking score of –9.827 kcal/mol and key interactions with residues such as Met-793, Leu-788, and Phe-856. Molecular dynamics simulations further confirmed the stability of the 5c-EGFR complex. ADMET predictions indicated favorable pharmacokinetic and safety profiles for 5c, including high permeability, oral absorption, and no significant toxicity. These findings highlight 5c as a promising lead compound for targeted lung cancer therapy, warranting further preclinical studies.
Zitieren
APA
Şenol, H., Tokalı, F. S., Ateşoğlu, Ş., Çakır, F., Şenol, A. M., Tokalı, P., Akbaş, F., & Kalay, E. (2025). Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents. Synlett, 36(17), 2939-2947. https://doi.org/10.1055/a-2541-1072
Vancouver
Şenol H, Tokalı FS, Ateşoğlu Ş, Çakır F, Şenol AM, Tokalı P, et al. Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents. Synlett. 2025;36(17):2939-2947. doi:10.1055/a-2541-1072
BibTeX
@article{enol2025,
author = {Şenol, Halil and Tokalı, Feyzi Sinan and Ateşoğlu, Şeyma and Çakır, Furkan and Şenol, Ayşe Merve and Tokalı, Pelin and Akbaş, Fahri and Kalay, Erbay},
title = {Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents},
journal = {Synlett},
year = {2025},
volume = {36},
number = {17},
pages = {2939--2947},
doi = {10.1055/a-2541-1072}
}
EUVIMED